5-methoxytryptamine has been researched along with Heart Defects, Congenital in 1 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mustafin, AA | 1 |
| Nigmatullina, RR | 1 |
| Mirolyubov, LM | 1 |
1 other study available for 5-methoxytryptamine and Heart Defects, Congenital
| Article | Year |
|---|---|
Functional activity of 5-HT4 receptors in children with congenital heart disease.
Topics: 5-Methoxytryptamine; Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Heart At | 2006 |